Skip to main content
  • Main menu
  • User menu
  • Search

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Research ArticleResearch

Alumina Depyrogenates F 18 Fludeoxyglucose Injection during Purification Processes

James F. Cooper, Neil A. Petry, Hendrik Engelbrecht and Kenneth Breslow
PDA Journal of Pharmaceutical Science and Technology May 2012, 66 (3) 214-220; DOI: https://doi.org/10.5731/pdajpst.2012.00860
James F. Cooper
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jimandfran@earthlink.net
Neil A. Petry
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hendrik Engelbrecht
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth Breslow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 66 no. 3 214-220
DOI 
https://doi.org/10.5731/pdajpst.2012.00860
PubMed 
22634587

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online May 26, 2012.

Copyright & Usage 
© PDA, Inc. 2012

Author Information

  1. James F. Cooper1,*,
  2. Neil A. Petry2,
  3. Hendrik Engelbrecht3 and
  4. Kenneth Breslow4
  1. 1Endotoxin Consulting, POB 9435, Greensboro, NC 27429-0435;
  2. 2Clinical Assistant Professor, Radiology, Duke University Medical Center, Durham, NC;
  3. 3Radiochemist, Precision Nuclear, Gray, TN; and
  4. 4Senior Regulatory Affairs Specialist, PETNET Solutions, A Siemens Company, Knoxville, TN
  1. ↵* Author to whom correspondence should be addressed: James F. Cooper, MS, PharmD, P.O. Box 9435, Greensboro, 27429-0435. Phone: (336) 210-5714. Email: jimandfran@earthlink.net
View Full Text

Cited By...

  • 1 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Pitfalls and Limitations of SPECT, PET, and Therapeutic Radiopharmaceuticals
    James R. Ballinger
    Seminars in Nuclear Medicine 2015 45 5
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 66 (3)
PDA Journal of Pharmaceutical Science and Technology
Vol. 66, Issue 3
May/June 2012
  • Table of Contents
  • Index by Author
Print
Download PDF
Article Alerts
Email Article
Citation Tools
Share
Alumina Depyrogenates F 18 Fludeoxyglucose Injection during Purification Processes
James F. Cooper, Neil A. Petry, Hendrik Engelbrecht, Kenneth Breslow
PDA Journal of Pharmaceutical Science and Technology May 2012, 66 (3) 214-220; DOI: 10.5731/pdajpst.2012.00860
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Conclusions
    • Conflict of Interest Declaration
    • Acknowledgments
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • A proof-of-concept study on a universal standard kit to evaluate the risks of inspectors for their foundational ability of visual inspection of injectable drug products
  • Understanding Alignment in the Execution of Extractable Screening Studies Between Laboratories: Results of the ELSIE Lab Practices Sub-Team Industry Surveys
  • Definition of Particle Visibility Threshold in Parenteral Drug Products—Towards Standardization of Visual Inspection Operator Qualification
Show more Research

Similar Articles

  • Leachables Analysis from a Closed Connected Single-Use mAb Purification Process
  • Evaluation of extreme depyrogenation conditions on the surface hydrolytic resistance of glass containers for pharmaceutical use
  • Proceedings of the 2017 Viral Clearance Symposium, Session 2.2: DSP Unit Operations–Purification Unit Operations
  • Determining the Clearance of Degraded Protein via a Monoclonal Antibody Purification Process in Support of Cleaning Carryover Limits in Multiproduct Facilities
  • Identification and Root Cause Analysis of the Visible Particles Commonly Encountered in the Biopharmaceutical Industry
See more

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire
Alerts for this Article
Sign In to Email Alerts with your Email Address
Email this Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Alumina Depyrogenates F 18 Fludeoxyglucose Injection during Purification Processes
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
10 + 10 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Alumina Depyrogenates F 18 Fludeoxyglucose Injection during Purification Processes
James F. Cooper, Neil A. Petry, Hendrik Engelbrecht, Kenneth Breslow
PDA Journal of Pharmaceutical Science and Technology May 2012, 66 (3) 214-220; DOI: 10.5731/pdajpst.2012.00860

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

We use cookies on this site to enhance your user experience

By clicking any link on this page you are giving your consent for us to set cookies.